CIK 0001739410 · <br>Emerging growth company
Rallybio Corp
Sign in to watch- Ticker
- RLYB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851083789
- Phone
- 203- 859-3820
- Business address
- 234 CHURCH STREET, SUITE 1020, NEW HAVEN, CT, 06510
- Former names
- Rallybio Holdings, LLC
- 424B3 Offering Prospectus
- S-4/A Deal Registration Statement - Business Combination
- 4 Option exercise Director acquired 14,820 shares (option exercise)
- 4 Option exercise Chief Financial Officer acquired 3,910 shares (option exercise)
- 4 Option exercise Chief Executive Officer acquired 22,456 shares (option exercise)
- S-4/A Deal Registration Statement - Business Combination
- 4 Option exercise Chief Financial Officer acquired 5,000 shares (option exercise)
- 4 Option exercise Director acquired 12,044 shares (option exercise)
- 4 Option exercise Director acquired 3,562 shares (option exercise)
- S-4/A Deal Registration Statement - Business Combination
- 8-K Event Executive or director change
- S-4/A Deal Registration Statement - Business Combination
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- S-4 Deal Registration Statement - Business Combination
- 4 Option exercise Director acquired 3,562 shares (option exercise)
Page 2 of 16 · 312 filings